BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23287365)

  • 1. SMILES-based QSAR model for arylpiperazines as high-affinity 5-HT(1A) receptor ligands using CORAL.
    Veselinović AM; Milosavljević JB; Toropov AA; Nikolić GM
    Eur J Pharm Sci; 2013 Feb; 48(3):532-41. PubMed ID: 23287365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMILES-based QSAR models for the calcium channel-antagonistic effect of 1,4-dihydropyridines.
    Veselinović AM; Milosavljević JB; Toropov AA; Nikolić GM
    Arch Pharm (Weinheim); 2013 Feb; 346(2):134-9. PubMed ID: 23280520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. coral Software: QSAR for Anticancer Agents.
    Benfenati E; Toropov AA; Toropova AP; Manganaro A; Gonella Diaza R
    Chem Biol Drug Des; 2011 Jun; 77(6):471-6. PubMed ID: 21435183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CORAL: QSPR model of water solubility based on local and global SMILES attributes.
    Toropov AA; Toropova AP; Benfenati E; Gini G; Leszczynska D; Leszczynski J
    Chemosphere; 2013 Jan; 90(2):877-80. PubMed ID: 22921649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR study on the affinity of some arylpiperazines towards the 5-HT1A/alpha1-adrenergic receptor using the E-state index.
    Debnath B; Samanta S; Naskar SK; Roy K; Jha T
    Bioorg Med Chem Lett; 2003 Sep; 13(17):2837-42. PubMed ID: 14611840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSAR as a random event: modeling of nanoparticles uptake in PaCa2 cancer cells.
    Toropov AA; Toropova AP; Puzyn T; Benfenati E; Gini G; Leszczynska D; Leszczynski J
    Chemosphere; 2013 Jun; 92(1):31-7. PubMed ID: 23566368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CORAL: QSPR modeling of rate constants of reactions between organic aromatic pollutants and hydroxyl radical.
    Toropov AA; Toropova AP; Rasulev BF; Benfenati E; Gini G; Leszczynska D; Leszczynski J
    J Comput Chem; 2012 Sep; 33(23):1902-6. PubMed ID: 22641453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding modes of chain arylpiperazines to 5-HT1a, 5-HT2a and 5-HT7 receptors.
    Bielenica A; Kozioł AE; Struga M
    Mini Rev Med Chem; 2013 Aug; 13(10):1516-39. PubMed ID: 24568298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-dimensional QSAR studies on arylpiperazines as high-affinity 5-HT(1A) receptor ligands.
    Weber KC; Honório KM; Andricopulo AD; Da Silva AB
    Med Chem; 2008 Jul; 4(4):328-35. PubMed ID: 18673144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monte Carlo QSAR models for predicting organophosphate inhibition of acetycholinesterase.
    Veselinović JB; Nikolić GM; Trutić NV; Živković JV; Veselinović AM
    SAR QSAR Environ Res; 2015 Jun; 26(6):449-60. PubMed ID: 26043064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSAR models for toxicity of organic substances to Daphnia magna built up by using the CORAL freeware.
    Toropova AP; Toropov AA; Benfenati E; Gini G
    Chem Biol Drug Des; 2012 Mar; 79(3):332-8. PubMed ID: 22136580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of retention characteristics of heterocyclic compounds.
    Nesměrák K; Toropov AA; Toropova AP; Yildiz I; Yalcin I; Brozikova M; Klimešová V; Waisser K
    Anal Bioanal Chem; 2015 Dec; 407(30):9185-9. PubMed ID: 26427498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
    Franchini S; Prandi A; Baraldi A; Sorbi C; Tait A; Buccioni M; Marucci G; Cilia A; Pirona L; Fossa P; Cichero E; Brasili L
    Eur J Med Chem; 2010 Sep; 45(9):3740-51. PubMed ID: 20605276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational methods in determination of pharmacophore models of 5-HT(1A), 5-HT(2A) and 5-HT(7) receptors.
    Bielenica A; Kozioł AE; Struga M
    Mini Rev Med Chem; 2013 Jun; 13(7):933-51. PubMed ID: 23544602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CORAL: QSAR models for acute toxicity in fathead minnow (Pimephales promelas).
    Toropova AP; Toropov AA; Lombardo A; Roncaglioni A; Benfenati E; Gini G
    J Comput Chem; 2012 May; 33(12):1218-23. PubMed ID: 22371019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α₁- and serotonine 5-HT1A receptors.
    Prandi A; Franchini S; Manasieva LI; Fossa P; Cichero E; Marucci G; Buccioni M; Cilia A; Pirona L; Brasili L
    J Med Chem; 2012 Jan; 55(1):23-36. PubMed ID: 22145629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CORAL Software: Analysis of Impacts of Pharmaceutical Agents Upon Metabolism via the Optimal Descriptors.
    Toropova MA; Raska I; Toporova AP; Raskova M
    Curr Drug Metab; 2017; 18(6):500-510. PubMed ID: 28260514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative structure-affinity relationship of 5-HT1A receptor ligands by the classification tree method.
    Kuz'min VE; Polischuk PG; Artemenko AG; Makan SY; Andronati SA
    SAR QSAR Environ Res; 2008; 19(3-4):213-44. PubMed ID: 18484496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simplified molecular input line entry system-based optimal descriptors: QSAR modelling for voltage-gated potassium channel subunit Kv7.2.
    Achary PG
    SAR QSAR Environ Res; 2014; 25(1):73-90. PubMed ID: 24580100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacophore-based 3D QSAR studies on a series of high affinity 5-HT1A receptor ligands.
    Weber KC; Salum LB; Honório KM; Andricopulo AD; da Silva AB
    Eur J Med Chem; 2010 Apr; 45(4):1508-14. PubMed ID: 20133028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.